Mark A. Tepper
Medical Devices
Corbus Pharmaceuticals
Australia
Biography
Mark A. Tepper, Ph.D., co-founded the Company in 2009. He has more than twenty years of leadership experience in pharmaceutical R&D and his past roles include leadership positions at Bristol Myers Squibb, Serono, CytRx, RXi Pharmaceuticals and NKT Therapeutics. Dr. Tepper has led teams in the discovery and development of a number of first-in-class drugs, including Guspermis, Taxol, Rebif, Orcenia and Gonal-F. During the last 10 years Dr. Tepper has focused his career on identifying unique early stage biotechnology assets, which fill a significant unmet medical need and forming companies to commercialize these assets. In this role, he has successfully founded and developed the commercialization strategy for 3 new biotech companies, raising over $45M in funding. Dr. Tepper received a Ph.D. in Biochemistry & Biophysics from Columbia University, College of Physicians & Surgeons, New York, and a B.A. in Chemistry with Highest Honors from Clark University, Worcester, Mass. He gained postdoctoral training at the University of Massachusetts Medical School, Worcester, MA in the laboratory of Professor Michael P. Czech.
Research Interest
Medical Devices
